Donor Age and Ischemic Time Are the Only Marginal Donor Criteria That Effect Survival for Lung Transplantation

2015 ◽  
Vol 34 (4) ◽  
pp. S282
Author(s):  
E.M. Schumer ◽  
J.R. Trivedi ◽  
M. Bousamra ◽  
V.H. van Berkel
CHEST Journal ◽  
2000 ◽  
Vol 118 (5) ◽  
pp. 1255-1262 ◽  
Author(s):  
Dan M. Meyer ◽  
Leah E. Bennett ◽  
Richard J. Novick ◽  
Jeffrey D. Hosenpud

2015 ◽  
Vol 34 (4) ◽  
pp. S46-S47
Author(s):  
B.C. Gulack ◽  
A.M. Ganapathi ◽  
P.J. Speicher ◽  
B.R. Englum ◽  
L.D. Snyder ◽  
...  

2017 ◽  
Vol 31 (7) ◽  
pp. e12993 ◽  
Author(s):  
Michael S. Mulvihill ◽  
Brian C. Gulack ◽  
Asvin M. Ganapathi ◽  
Paul J. Speicher ◽  
Brian R. Englum ◽  
...  

2005 ◽  
Vol 15 (1) ◽  
pp. 24-26 ◽  
Author(s):  
Alexia Michaelides ◽  
Willie Koen

Recipients receiving heart transplants from 83 donors from 1995 to 2002 were analyzed to evaluate the effect of various donor factors on recipient outcomes. The 83 donors (13 women and 70 men; 2–51 years old) had cold ischemic times ranging between 55 and 287 minutes. Donor age, cause of death, inotropic support, and cold ischemic times of the hearts were compared to 1-year left ventricular ejection fraction, permanent pacemaker dependency, 30-day mortality, and 1-year survival in the recipients. Donors receiving low-dose inotropic support resulted in recipients with permanent pacemaker dependency in 14.8%, and 30-day mortality and 1-year survival rates of 7.4% and 70.3%, respectively. Donors not receiving inotropic support resulted in recipients with permanent pacemaker dependency in 3.5%, and 30-day mortality and 1-year survival of 3.5% and 83.9%, respectively. Cold ischemic times less than or equal to 120 minutes showed 30-day mortality and 1-year survival rates of 0% and 90.9%, respectively. Cold ischemic times equal to or more than 121 minutes showed 30-day mortality and 1-year survival rates of 8% and 76%, respectively. Increased donor age ( P=.22) and cold ischemic time showed an increase in mortality without affecting mean ejection fraction in survivors. Use of inotropic support in donors ( P=.95) showed an increase in mortality without affecting mean ejection fraction in survivors.


2018 ◽  
Vol 37 (4) ◽  
pp. S247-S248
Author(s):  
M. Fakhro ◽  
H. Ghaidan ◽  
L. Algotsson ◽  
H. Larsson ◽  
S. Lindstedt

2001 ◽  
Vol 20 (12) ◽  
pp. 1291-1296 ◽  
Author(s):  
Steven M Fiser ◽  
Irving L Kron ◽  
Stewart M Long ◽  
Aditya K Kaza ◽  
John A Kern ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document